WGS
GeneDx Holdings Corp.
Key Financials
Net Income
$-21021000
↑ 59.8%
Revenue
$427.5M
↑ 40.0%
EPS (Diluted)
$-0.73
↑ 62.4%
Gross Profit
$298.2M
↑ 53.4%
Operating Income
$-13077000
↑ 43.7%
Total Assets
$523.7M
↑ 24.9%
Total Liabilities
$215.5M
↑ 23.8%
Shareholders' Equity
$308.2M
↑ 25.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/15/2026 | View on SEC |
| SCHEDULE 13D/A | 5/15/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| SCHEDULE 13D/A | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 10-Q | 5/4/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| 4 | 5/1/2026 | View on SEC |
| 4 | 5/1/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | WGS |
| Company Name | GeneDx Holdings Corp. |
| CIK | 1818331 |
| Sector | Services-Health Services |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8000 |
| SIC Description | Services-Health Services |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 888-729-1206 |